Humanized anti-CD70 binding agents and uses thereof

Details for Australian Patent Application No. 2006236225 (hide)

Owner Seattle Genetics, Inc.

Inventors McEarchern, Julie; Law, Che-Leung; McDonagh, Charlotte; Carter, Paul

Agent Spruson & Ferguson

Pub. Number AU-B-2006236225

PCT Pub. Number WO2006/113909

Priority 60/673,070 19.04.05 US

Filing date 19 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 10 May 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113909 Priority application(s): WO2006/113909

10 May 2012 Application Accepted

  Published as AU-B-2006236225

6 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236226-Inhibitors of microsomal triglyceride transfer protein and Apo-B secretion

2006236216-Methods and devices for relieving stress